Colleen Toole, Ph.D.
Director of Project Management
Colleen Toole, Ph.D. has joined CeeTox in the newly-created position of Director of Project Management. She brings a strong background in central laboratory services as well as scientific laboratory products to the role.
Dr. Toole graduated with high honors from the doctoral program at Tulsa University under the direction of Dr. Lamont Anderson in Molecular Biology. She pursued postdoctoral training at Martek Biosciences located in Columbia MD, working to develop and market proprietary technology “Rd Flip” (Recombinantly-derived Fluorescently-labeled Interrogation Probes) for high-throughput assays based upon cyanobacterial and red algal-derived fluorescent proteins (phycobilisomes and phycobiliproteins).
Dr. Toole developed assays and investigated kinase, phosphatase, methylase inhibitors and activators, utilizing a microfuidic platform while at Amphora Discovery in RTP, North Carolina. She was Team Leader for the AKT project. As Director of Molecular Biology at Cayman Chemical Company, she initiated and directed the molecular biology/protein expression core group. She was later named Manager of Preclinical Drug Discovery for Cayman Chemical. Dr. Toole has extensive experience in assay development utilizing various readouts including luminescence, absorbance, fluorescence, fluorescence polarization, FRET, TR-FRET and microfuidics.
As Director of Project Management for CeeTox, she leads the scientific services division, managing the progress of all client studies as well as providing technical liaison to the sales team. Dr. Toole has received numerous research awards and has co-authored peer-reviewed articles and presented many papers at national scientific meetings.